Abstract
Endothelial lipase (EL) is a novel member of the triglyceride (TG) lipase family. A growing body of evidence has indicated that EL gene polymorphism might contribute to the process of cardiovascular diseases. This study was aimed to reveal the potential relationship between EL −384A/C gene polymorphism and acute coronary syndrome (ACS) in a Chinese Han population. The subjects were composed of 320 ACS patients and 315 age- and gender- matched controls. We detected the EL −384A/C genotypes and allele frequencies by using polymerase chain reaction-restriction fragment length polymorphism analysis. There was significant difference in AA genotype and AC+CC genotype between ACS and control groups (P = 0.014). The A allele frequency was significantly higher in ACS group than in control group (87.8 vs 83.8 %, P = 0.041). The relationship between the variant and ACS remained significant after adjusting for current smoker, hypertension, diabetes mellitus, total cholesterol and TG (OR = 0.682, 95 % CI = 0.472–0.986). The levels of HDL and ApoA-I were significantly higher in AC+CC genotype than in AA genotype (HDL: 1.20 ± 0.35 vs 1.11 ± 0.29 mmol/L, P = 0.001; ApoA-I: 1.14 ± 0.25 vs 1.08 ± 0.21 g/L, P = 0.009). We found that the EL −384A/C gene polymorphism might be associated with ACS in Chinese Han population, suggesting that the variant might be involved in the pathogenesis of ACS.
Similar content being viewed by others
Abbreviations
- ACS:
-
Acute coronary syndrome
- CAD:
-
Coronary artery disease
- LDL:
-
Low density lipoprotein
- HDL:
-
High density lipoprotein
- TG:
-
Triglyceride
- LPL:
-
Lipoprotein lipase
- HL:
-
Hepatic lipase
- CVD:
-
Cardiovascular disease
- BP:
-
Blood pressure
- PCR–RFLP:
-
Polymerase chain reaction–restriction fragment length polymorphism analysis
- SPSS:
-
Statistical package for the social sciences
- SNPs:
-
Single-nucleotide polymorphisms
- Apo:
-
Apolipoprotein
- TC:
-
Total cholesterol
- LP(a):
-
Lipoprotein(a)
- AS:
-
Atherosclerosis
References
Achari V, Thakur AK (2004) Association of major modifiable risk factors among patients with coronary artery disease: a retrospective analysis. J Assoc Physicians India 52:103–108
Maron DJ (2000) The epidemiology of low levels of high-density lipoprotein cholesterol in patients with and without coronary artery disease. Am J Cardiol 86(12A):11–14
Saedi M, Vaisi-Raygani A, Khaghani S, Shariftabrizi A, Rezaie M, Pasalar P, Rahimi Z, Pourmotabbed T (2012) Matrix metalloproteinas-9 functional promoter polymorphism 1562C > T increased risk of early-onset coronary artery disease. Mol Biol Rep 39:555–562
Zhou X, Chen J, Xu W (2012) Association between C1431T polymorphism in peroxisome proliferator-activated receptor-gamma gene and coronary artery disease in Chinese Han population. Mol Biol Rep 39(2):1863–1868
Ergen A, Isbir S, Timirci O, Tekeli A, Isbir T (2011) Effects of myeloperoxidase −463 G/A gene polymorphism and plasma levels on coronary artery disease. Mol Biol Rep 38(2):887–891
Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 62:707–714
Tang NP, Wang LS, Yang L, Zhou B, Gu HJ, Sun QM, Cong RH, Zhu HJ, Wang B (2008) Protective effect of an endothelial lipase gene variant on coronary artery disease in a Chinese population. J Lipid Res 49:369–375
Shimizu M, Kanazawa K, Hirata K, Ishida T, Hiraoka E, Matsuda Y, Iwai C, Miyamoto Y, Hashimoto M, Kajiya T, Akita H, Yokoyama M (2007) Endothelial lipase gene polymorphism is associated with acute myocardial infarction, independently of high-density lipoprotein-cholesterol levels. Circ J 71:842–846
Vergeer M, Cohn DM, Boekholdt SM, Sandhu MS, Prins HM, Ricketts SL, Wareham NJ, Kastelein JJ, Khaw KT, Kamphuisen PW, Dallinga-Thie GM (2010) Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT. Atherosclerosis 211:558–564
Yamakawa-Kobayashi K, Yanagi H, Endo K, Arinami T, Hamaguchi H (2003) Relationship between serum HDL-C levels and common genetic variants of the endothelial lipase gene in Japanese school-aged children. Hum Genet 113:311–315
Hutter CM, Austin MA, Farin FM, Viernes HM, Edwards KL, Leonetti DL, McNeely MJ, Fujimoto WY (2006) Association of endothelial lipase gene (LIPG) haplotypes with high-density lipoprotein cholesterol subfractions and apolipoprotein AI plasma levels in Japanese Americans. Atherosclerosis 185:78–86
Alpert JS, Thygesen K, Antman E, Bassand JP (2000) Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 36:959–969
Kallner A, Estonius M (2006) Measurement of apolipoproteins is better than routinely measured traditional lipids. Lakartidningen 103(753–756):758
Goswami B, Rajappa M, Mallika V, Kumar S, Shukla DK (2008) Apo-B/apo-AI ratio: a better discriminator of coronary artery disease risk than other conventional lipid ratios in Indian patients with acute myocardial infarction. Acta Cardiol 63:749–755
Chien KL, Hsu HC, Su TC, Chen MF, Lee YT, Hu FB (2007) Apolipoprotein B and non-high density lipoprotein cholesterol and the risk of coronary heart disease in Chinese. J Lipid Res 11:2499–2505
McCy MG, Sun GS, Marchadier D, Maugeais C, Glick JM, Rader DJ (2002) Characterization of the lipolytic activity of endothelial lipase. J Lipid Res 43:921–929
Tanaka H, Ishida T, Johnston TP, Yasuda T, Ueyama T, Kojima Y, Kundu RK, Quertermous T, Ishikawa Y, Hirata K (2009) Role of endothelial lipase in plasma HDL levels in a murine model of hypertriglyceridmia. J Atheroscler Thromb 16:327–338
Ishida T, Choi S, Kundu RK, Hirata K, Rubin EM, Cooper AD, Quertermous T (2003) Endothelial lipase is a major determinant of HDL level. J Clin Invest 111:347–355
Ma K, Cilingiroglu M, Otvos JD, Ballantyne CM, Marian AJ, Chan L (2003) Endothelial lipase is a major genetic determinant for high-density lipoprotein concentration, structure, and metabolism. Proc Natl Acad Sci USA 100:2748–2753
Hara T, Ishida T, Kojima Y, Tanaka H, Yasuda T, Shinohara M, Toh R, Hirata K (2011) Targeted deletion of endothelial lipase increases HDL particles with anti-inflammatory properties both in vitro and in vivo. J Lipid Res 52:57–67
Jin W, Millar JS, Broedl U, Glick JM, Rader DJ (2003) Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo. J Clin Invest 111:357–362
Ishida T, Choi SY, Kundu RK, Spin J, Yamashita T, Hirata K, Kojima Y, Yokoyama M, Cooper AD, Quertermous T (2004) Endothelial lipase modulates susceptibility to atherosclerosis in apolipoprotein-E-deficient mice. J Biol Chem 279:45085–45092
Yasuda T, Hirata K, Ishida T, Kojima Y, Tanaka H, Okada T, Quertermous T, Yokoyama M (2007) Endothelial lipase is increased by inflammation and promotes LDL uptake in macrophages. J Atheroscler Thromb 14:192–201
Shiu SW, Tan KC, Huang Y, Wong Y (2008) Type 2 diabetes mellitus and endothelial lipase. Atherosclerosis 198:441–447
Badellino KO, Wolfe ML, Reilly MP, Rader DJ (2006) Endothelial lipase concentrations are increased in metabolic syndrome and associated with coronary atherosclerosis. PLoS Med 3:e22
Fang YQ, Huang L, Li AM, Song YM, Jin J, Geng ZH, Yu XJ, Deng MY (2007) Significance of the ratio of circulating endothelial cell expressing endothelial lipase and supersensitivity C-reactive protein in prognosis of patients with coronary artery disease. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue (Chin) 19:644–646
deLemos AS, Wolfe ML, Long CJ, Sivapackianathan R, Rader DJ (2002) Identification of genetic variants in endothelial lipase in persons with elevated high-density lipoprotein cholesterol. Circulation 106:1321–1326
Edmondson AC, Brown RJ, Kathiresan S, Cupples LA, Demissie S, Manning AK, Jensen MK, Rimm EB, Wang J, Rodrigues A, Bamba V, Khetarpal SA, Wolfe ML, Derohannessian S, Li M, Reilly MP, Aberle J, Evans D, Hegele RA, Rader DJ (2009) Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans. J Clin Invest 119:1042–1050
Liu WY, Yin RX, Zhang L, Cao XL, Miao L, Wu DF, Aung LH, Hu XJ, Lin WX, Yang DZ (2010) Association of the LIPG 584C > T polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations. Lipids Health Dis 9:110
Durlach V, Durlach A, Movesayan I, Socquard E, Zellner C, Clavel C, Nazeyrollas P, Malloy MJ, Pullinger CR, Kane JP, Ducasse A, Aouizerat BE (2011) Association of endothelial lipase Thr111Ile polymorphism with lipid metabolism and microvascular complications in type 2 diabetic patients. Diabetes Metab 37:64–71
Jensenm MK, Rimm EB, Mukamal KJ, Edmondson AC, Raderm DJ, Vogel U, Tjonneland A, Sorensen TI, Schmidt EB, Overvad K (2009) The T111I variant in the endothelial lipase gene and risk of coronary heart disease in three independent populations. Eur Heart J 30:1584–1589
Huang Y, Bai H, Fan P, Liu R, Liu Y, Liu BW (2008) The −384A > C polymorphism of endothelial lipase gene promoter region in Chinese healthy normolipidemic and endogenous hypertriglyceridemic subjects. Zhonghua Yi Xue Yi Chuan Xue Za Zhi (Chin) 25:443–446
Acknowledgments
This work was supported by the Science and technology project of Wujin (WS2010010). The authors are grateful to the staff of the department of Cardiology, Wujin Hospital for their facilitation in the sample collection.
Conflict of interest
The authors declare that they have no competing interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cai, G., He, G. & Qi, C. The association between endothelial lipase −384A/C gene polymorphism and acute coronary syndrome in a Chinese population. Mol Biol Rep 39, 9879–9884 (2012). https://doi.org/10.1007/s11033-012-1854-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-012-1854-y